Evidence map›Paper›PMID 39086558›Full record

ArticleApplied sciences (Basel, Switzerland)2023

Using Ensemble OCT-Derived Features beyond Intensity Features for Enhanced Stargardt Atrophy Prediction with Deep Learning.

Zubin Mishra, Ziyuan Wang, SriniVas R Sadda, Zhihong Hu

Abstract read
In one paragraph

Article in Applied sciences (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zubin MishraDoheny Image Analysis Laboratory, Doheny Eye Institute, Pasadena, CA 91103, USA.
Ziyuan WangDoheny Image Analysis Laboratory, Doheny Eye Institute, Pasadena, CA 91103, USA.
SriniVas R SaddaDoheny Image Analysis Laboratory, Doheny Eye Institute, Pasadena, CA 91103, USA.
Zhihong HuDoheny Image Analysis Laboratory, Doheny Eye Institute, Pasadena, CA 91103, USA.ORCID 0000-0001-8307-0298

Funding

Artificial Intelligence for Assessment of Stargardt Macular AtrophyR21EY029839 · NEI · DOHENY EYE INSTITUTE · PI HU, ZHIHONG, SADDA, SRINIVAS R · 2020 to 2021
$426k
NEI NIH HHS R21 EY029839
6 · The paper itself

Abstract

Stargardt disease is the most common form of juvenile-onset macular dystrophy. Spectral-domain optical coherence tomography (SD-OCT) imaging provides an opportunity to directly measure changes to retinal layers due to Stargardt atrophy. Generally, atrophy segmentation and prediction can be conducted using mean intensity feature maps generated from the relevant retinal layers. In this paper, we report an approach using advanced OCT-derived features to augment and enhance data beyond the commonly used mean intensity features for enhanced prediction of Stargardt atrophy with an ensemble deep learning neural network. With all the relevant retinal layers, this neural network architecture achieves a median Dice coefficient of 0.830 for six-month predictions and 0.828 for twelve-month predictions, showing a significant improvement over a neural network using only mean intensity, which achieved Dice coefficients of 0.744 and 0.762 for six-month and twelve-month predictions, respectively. When using feature maps generated from different layers of the retina, significant differences in performance were observed. This study shows promising results for using multiple OCT-derived features beyond intensity for assessing the prognosis of Stargardt disease and quantifying the rate of progression.

Indexed as

advanced OCT-derived featuresbiomedical optical imagingdata augmentation and enhancementensemble deep convolutional neural networksoptical coherence tomographypredictive models

Identifiers

PMID39086558
PMCPMC11288976

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.